Myeloid apolipoprotein E controls dendritic cell antigen presentation and T cell activation

[1]  V. D’Agati,et al.  Cholesterol Accumulation in Dendritic Cells Links the Inflammasome to Acquired Immunity. , 2017, Cell metabolism.

[2]  J. Witztum,et al.  Cholesterol Accumulation in CD11c+ Immune Cells Is a Causal and Targetable Factor in Autoimmune Disease. , 2016, Immunity.

[3]  Wei Yang,et al.  Potentiating the antitumour response of CD8+ T cells by modulating cholesterol metabolism , 2016, Nature.

[4]  E. Pearce,et al.  Immunometabolism governs dendritic cell and macrophage function , 2016, The Journal of experimental medicine.

[5]  R. Sun,et al.  Limiting Cholesterol Biosynthetic Flux Spontaneously Engages Type I IFN Signaling , 2015, Cell.

[6]  T. Schoeb,et al.  Cholesterol-Independent Suppression of Lymphocyte Activation, Autoimmunity, and Glomerulonephritis by Apolipoprotein A-I in Normocholesterolemic Lupus-Prone Mice , 2015, The Journal of Immunology.

[7]  M. Netea,et al.  The Cellular and Molecular Basis of Translational Immunometabolism. , 2015, Immunity.

[8]  J. Bagley,et al.  Hyperlipidemia Promotes Anti‐Donor Th17 Responses That Accelerate Allograft Rejection , 2015, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[9]  K. Waddington,et al.  Manipulating membrane lipid profiles to restore T-cell function in autoimmunity. , 2015, Biochemical Society transactions.

[10]  E. Gratton,et al.  LXRs link metabolism to inflammation through Abca1-dependent regulation of membrane composition and TLR signaling , 2015, eLife.

[11]  G. Norata,et al.  HDL in innate and adaptive immunity. , 2014, Cardiovascular research.

[12]  P. Blackshear,et al.  APOε4 is associated with enhanced in vivo innate immune responses in human subjects. , 2014, The Journal of allergy and clinical immunology.

[13]  P. Shah,et al.  Cholesterol Lowering Modulates T Cell Function In Vivo and In Vitro , 2014, PloS one.

[14]  G. Norata,et al.  High density lipoprotein cholesterol levels are an independent predictor of the progression of chronic kidney disease , 2013, Journal of internal medicine.

[15]  D. Peng,et al.  HDL and ApoA-I inhibit antigen presentation-mediated T cell activation by disrupting lipid rafts in antigen presenting cells. , 2012, Atherosclerosis.

[16]  Andrew C. Li,et al.  Regulated Accumulation of Desmosterol Integrates Macrophage Lipid Metabolism and Inflammatory Responses , 2012, Cell.

[17]  P. Libby.  Inflammation in Atherosclerosis , 2012, Arteriosclerosis, thrombosis, and vascular biology.

[18]  S. Cremers,et al.  Regulation of hematopoietic stem and progenitor cell mobilization by cholesterol efflux pathways. , 2012, Cell stem cell.

[19]  A. Chait,et al.  Apolipoprotein A-I Attenuates Palmitate-Mediated NF-κB Activation by Reducing Toll-Like Receptor-4 Recruitment into Lipid Rafts , 2012, PloS one.

[20]  A. Maseri,et al.  Effector Memory T cells Are Associated With Atherosclerosis in Humans and Animal Models , 2012, Journal of the American Heart Association.

[21]  Zhi-Sheng Jiang,et al.  Apolipoprotein A-I inhibits CD40 proinflammatory signaling via ATP-binding cassette transporter A1-mediated modulation of lipid raft in macrophages. , 2012, Journal of atherosclerosis and thrombosis.

[22]  A. Tall,et al.  ApoE regulates hematopoietic stem cell proliferation, monocytosis, and monocyte accumulation in atherosclerotic lesions in mice. , 2011, The Journal of clinical investigation.

[23]  A. Luster,et al.  CXCR3 in T cell function. , 2011, Experimental cell research.

[24]  H. Saito,et al.  Molecular basis for the differences in lipid and lipoprotein binding properties of human apolipoproteins E3 and E4. , 2010, Biochemistry.

[25]  K. Garlaschelli,et al.  Circulating CD4+CD25hiCD127lo Regulatory T-Cell Levels Do Not Reflect the Extent or Severity of Carotid and Coronary Atherosclerosis , 2010, Arteriosclerosis, thrombosis, and vascular biology.

[26]  A. Tall,et al.  ATP-Binding Cassette Transporters and HDL Suppress Hematopoietic Stem Cell Proliferation , 2010, Science.

[27]  A. Tall,et al.  Role of HDL, ABCA1, and ABCG1 transporters in cholesterol efflux and immune responses. , 2010, Arteriosclerosis, thrombosis, and vascular biology.

[28]  J. Brewer,et al.  Tracking dendritic cells in vivo. , 2010, Methods in molecular biology.

[29]  D. Noto,et al.  Effects of PCSK9 variants on common carotid artery intima media thickness and relation to ApoE alleles. , 2010, Atherosclerosis.

[30]  R. Orlando,et al.  A Jurkat transcriptional reporter cell line for high-throughput analysis of the nuclear factor-kappaB signaling pathway. , 2009, New biotechnology.

[31]  G. Hansson.  Inflammatory mechanisms in atherosclerosis , 2009, Journal of thrombosis and haemostasis : JTH.

[32]  R. Walzem,et al.  Apolipoprotein A-I and Its Role in Lymphocyte Cholesterol Homeostasis and Autoimmunity , 2009, Arteriosclerosis, thrombosis, and vascular biology.

[33]  R. Knorr,et al.  Endocytosis of MHC molecules by distinct membrane rafts , 2009, Journal of Cell Science.

[34]  R. Lechler,et al.  Conferring indirect allospecificity on CD4+CD25+ Tregs by TCR gene transfer favors transplantation tolerance in mice. , 2008, The Journal of clinical investigation.

[35]  Peter Tontonoz,et al.  LXR Signaling Couples Sterol Metabolism to Proliferation in the Acquired Immune Response , 2008, Cell.

[36]  A. Lanzavecchia,et al.  Simvastatin inhibits the MHC class II pathway of antigen presentation by impairing Ras superfamily GTPases , 2006, European journal of immunology.

[37]  Jonathan C. Cohen,et al.  Sterol Intermediates from Cholesterol Biosynthetic Pathway as Liver X Receptor Ligands* , 2006, Journal of Biological Chemistry.

[38]  Peter Libby,et al.  The immune response in atherosclerosis: a double-edged sword , 2006, Nature Reviews Immunology.

[39]  G. Norata,et al.  Effects of Fractalkine Receptor Variants on Common Carotid Artery Intima-Media Thickness , 2006, Stroke.

[40]  J. Yates,et al.  Location of Major Histocompatibility Complex Class II Molecules in Rafts on Dendritic Cells Enhances the Efficiency of T‐Cell Activation and Proliferation , 2006, Scandinavian journal of immunology.

[41]  F. Sacks,et al.  Apolipoprotein-mediated pathways of lipid antigen presentation , 2005, Nature.

[42]  F. Foufelle,et al.  SREBP transcription factors: master regulators of lipid homeostasis. , 2004, Biochimie.

[43]  J. Kapp,et al.  Evidence for Cooperativity in the Rejection of Cardiac Grafts Mediated by CD4+ TCR Tg T Cells Specific for a Defined Allopeptide , 2004, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[44]  R. Billingham,et al.  The H-Y antigen and its role in natural transplantation , 2004, Human Genetics.

[45]  A. Thomson,et al.  Dendritic cells: regulators of alloimmunity and opportunities for tolerance induction , 2003, Immunological reviews.

[46]  S. Bécart,et al.  MHC Class II-Peptide Complexes in Dendritic Cell Lipid Microdomains Initiate the CD4 Th1 Phenotype 1 , 2003, The Journal of Immunology.

[47]  D. Michaelson,et al.  Lack of apolipoprotein-E exacerbates experimental allergic encephalomyelitis , 2003, Multiple sclerosis.

[48]  Xinghua Zhou,et al.  Apolipoprotein E modulates immune activation by acting on the antigen‐presenting cell , 2003 .

[49]  P. Roche,et al.  MHC Class II-Peptide Complexes and APC Lipid Rafts Accumulate at the Immunological Synapse , 2003, The Journal of Immunology.

[50]  Peter Tontonoz,et al.  Reciprocal regulation of inflammation and lipid metabolism by liver X receptors , 2003, Nature Medicine.

[51]  Aldons J. Lusis,et al.  Identification of macrophage liver X receptors as inhibitors of atherosclerosis , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[52]  K. Honjo,et al.  HETEROGENEITY OF T CELL CLONES SPECIFIC FOR A SINGLE INDIRECT ALLOANTIGENIC EPITOPE (I-Ab/H-2Kd54–68) THAT MEDIATE TRANSPLANT REJECTION1 , 2000, Transplantation.

[53]  B. Rupp,et al.  Differences in stability among the human apolipoprotein E isoforms determined by the amino-terminal domain. , 2000, Biochemistry.

[54]  P. Roche,et al.  Concentration of MHC class II molecules in lipid rafts facilitates antigen presentation , 2000, Nature Immunology.

[55]  O. Lantz,et al.  γ chain required for naïve CD4+ T cell survival but not for antigen proliferation , 2000, Nature Immunology.

[56]  P. Bromberg.  Structure-Function Relationships , 1999 .

[57]  M. Miceli,et al.  Engagement of GPI-linked CD48 contributes to TCR signals and cytoskeletal reorganization: a role for lipid rafts in T cell activation. , 1998, Immunity.

[58]  A. von Eckardstein,et al.  Overexpression and Accumulation of Apolipoprotein E as a Cause of Hypertriglyceridemia* , 1998, The Journal of Biological Chemistry.

[59]  J. Chauvin,et al.  Engagement of T cell receptor triggers its recruitment to low‐density detergent‐insoluble membrane domains , 1998, The EMBO journal.

[60]  A. Daugherty,et al.  Apolipoprotein E-deficient mice have impaired innate immune responses to Listeria monocytogenes in vivo. , 1998, Journal of lipid research.

[61]  A. von Eckardstein,et al.  Phenotype-dependent differences in apolipoprotein E metabolism and in cholesterol homeostasis in human monocyte-derived macrophages. , 1998, The Journal of clinical investigation.

[62]  O. Yoshie,et al.  Secondary Lymphoid-tissue Chemokine Is a Functional Ligand for the CC Chemokine Receptor CCR7* , 1998, The Journal of Biological Chemistry.

[63]  F. Auger,et al.  Involvement of Male-Specific Minor Histocompatibility Antigen H-Y in Epidermal Equivalent Allograft Rejection , 1998 .

[64]  F. Auger,et al.  Involvement of male-specific minor histocompatibility antigen H-Y in epidermal equivalent allograft rejection. , 1998, Cell transplantation.

[65]  S. Barger,et al.  Microglial activation by Alzheimer amyloid precursor protein and modulation by apolipoprotein E , 1997, Nature.

[66]  J. Goldstein,et al.  The SREBP Pathway: Regulation of Cholesterol Metabolism by Proteolysis of a Membrane-Bound Transcription Factor , 1997, Cell.

[67]  J. Taylor,et al.  Macrophage-specific expression of human apolipoprotein E reduces atherosclerosis in hypercholesterolemic apolipoprotein E-null mice. , 1995, The Journal of clinical investigation.

[68]  K. Weisgraber.  Apolipoprotein E: structure-function relationships. , 1994, Advances in protein chemistry.

[69]  N. Maeda,et al.  Atherosclerosis in mice lacking apo E. Evaluation of lesional development and progression. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.

[70]  N. Maeda,et al.  Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E. , 1992, Science.

[71]  A. Rudensky,et al.  Sequence analysis of peptides bound to MHC class II molecules , 1991, Nature.

[72]  R. Terkeltaub,et al.  Apolipoprotein (apo) E inhibits the capacity of monosodium urate crystals to stimulate neutrophils. Characterization of intraarticular apo E and demonstration of apo E binding to urate crystals in vivo. , 1991, The Journal of clinical investigation.

[73]  C. Sing,et al.  Apolipoprotein E polymorphism and atherosclerosis. , 1988, Arteriosclerosis.

[74]  M. Thompson,et al.  Studies of cholesterol biosynthesis. I. The identification of desmosterol in serum and tissues of animals and man treated with MER-29. , 1960, The Journal of biological chemistry.